Page 306

send in a separate mailing an information packet providing the household information on contacting the nearest testing facility for purposes of submitting to a drug test. The packet must include the following four (4) documents: 1. MDHS-EA-337, TANF Drug Testing Instructions (the EW must use the list of TANF drug testing collection sites to locate the facility nearest to the client and enter the facility's information on the MDHS-EA-337.) 2. MedScreens/MDHS cover sheet 3. ePassport (single sheet with a bar code) 4. Chain of Custody and Control Form (multi sheet with a bar code) The eligibility worker (EW) must complete the following steps prior to mailing the information packet at the time the TANF approval (A101) notice is sent. • Complete the Applicant Information on the ePassport form with the client’s name, MAVERICS client ID and the Specimen ID (locate4d on the top right section of the Drug Testing Custody and Control Form). • Complete the Drug Testing Custody and Control Form with the client’s name (Section CName/ID) and MAVERICS client ID (Section D-Donor SSN or other ID). • Make a copy of the ePassport form prior to mailing it to the client. • Send the entire information packet containing the four items listed above, to the household. • On the same day, email the copy of the ePassport form to the eaescreen@mdhs.ms.gov email address and copy (cc) the County Director. This email account will be monitored by designated State Office staff and is to be bused only for this purpose. Document the case record. The adult will have seven (7) calendar days from the date of the TANF approval notice to report to the facility for drug testing. The adult may advise the testing facility of any current prescriptions or over-the-counter medications being taken. The case worker will notify the individual of the test results via MAVERICS notice A315, Notification of Drug Test Results. If results of the test are positive, the adult will be required to complete the treatment facility’s intake process and/or enter a drug treatment program approved by the Mississippi Department of Volume III | Chapter 3

3912